Treatment Planning Systems And Advanced Image Processing Market Size, Share & Trends Report

Treatment Planning Systems And Advanced Image Processing Market Size, Share & Trends Analysis Report By Component, By Technique, By Application (Adaptive Radiotherapy, Dose Accumulation), By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: May, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-4-68039-363-5
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 130

Report Overview

The global treatment planning systems and advanced image processing market size was valued at USD 1.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.8% from 2021 to 2028. The rapid increase in global cancer prevalence is driving the demand for innovative and accurate oncology treatment practices. Evolving healthcare IT sector with supportive infrastructure, the rising adoption of Artificial Intelligence (AI) and Machine Learning (ML) into oncology processes, rising investments in oncology treatment and care segments, and increased demand for innovative treatment solutions are fueling the market growth. For instance, Purdue Pharma L.P is investing in its oncology R&D to diversify the scientific research in high unmet medical need areas and thereby establishing a potential portfolio of delivering new cancer therapies to patients over the forthcoming years.

U.S. treatment planning system & advanced image processing market size, by component, 2016 - 2028 (USD Million)

The rapidly increasing prevalence of cancer and cancer-related mortalities at both global and regional levels is alarming. The rising numbers will boost demand for innovative treatment practices in the oncology space. As per Globocan estimates in 2020, approximately 19.3 million new cancer cases were diagnosed globally and 10.0 million cancer-related mortalities were recorded. Amongst these numbers, breast cancer (11.7%), lung cancer (11.4%), colorectal cancer (10.0%), prostate cancer (7.3%), and stomach cancer (5.6%) were the most common types of cancers recorded.

Furthermore, it is estimated that by 2040 more than 28.4 million new cancer cases would be diagnosed annually with a rise of 47.0% from 2020. Rising prevalence will boost demand for an accurate diagnosis to support adequate treatment plans. Radiotherapy is gaining popularity as one of the prominent and cost-effective treatment options. As per an International Journal of Medical Sciences research article, around 50.0% of cancer patients opt for radiotherapy due to its increased efficiency.

Radiotherapy is constantly innovating novel technologies that are capable of changing treatment processes completely. Healthcare infrastructure is transforming and market players are focusing on growth opportunities in emerging markets for the development of treatment planning. Additionally, government initiatives and support towards public-private partnerships in the oncology and radiotherapy space will accelerate product development and innovation. For instance, Elekta received Mexican government tender approval for radiation therapy solutions in 2018. The Australian government launched the Victorian RapidPlan Project to support the use of advanced radiation therapy practices. Similarly, Barwon Health Foundation inaugurated the redeveloped Andrew Love Cancer Centre Chemotherapy Day Ward and Oncology Pharmacy and collaborated with Varian Medical Systems to provide treatment planning and radiation therapy systems in 2019.

Market players are widely adopting artificial intelligence and machine learning in their oncology software solutions to enhance diagnosis, treatment plan, simulation, and cancer care management. AI/ML-enabled algorithms are used for image segmentation and detection of clinically important areas. Furthermore, the use of AI in cancer screening and diagnosis aids in treatment planning processes and prevents chances of collateral tissue damage. Numerous projects and initiatives are being taken up by organizations to amalgamate AI/ML into their solutions. For instance, the American College of Radiology founded the Data Science Institute to promote collaboration amongst radiologists, private and public agencies to adopt and develop AI-based imaging solutions. Similarly, the American Society of Clinical Oncology and American Society for Radiation Oncology initiated CancerLinQ and the National Institute of Health founded Big Data to Knowledge initiative.

Moreover, cancer prognosis in the future would be AI-enabled which would support early diagnosis of cancer using machine learning and deep learning algorithms. For instance, in 2019, RaySearch Laboratories demonstrated a U.S. FDA-approved treatment planning system with machine learning capabilities. Treatment planning systems are witnessing a widespread adoption with the increased accessibility of radiotherapy centers and strategic collaborations of major players to develop technologically advanced solutions. For instance, Accuray Inc collaborated with multiple Japanese hospitals and provided them with Accuray Radixact System in 2020. This collaboration is expected to increase Accuray and its treatment planning solutions’ visibility in the oncology market in Japan.

In addition, players in the treatment planning systems market are continuously innovating and launching advanced solutions to meet the growing demand for accurate oncology treatment solutions. For instance, Accuray Inc launched Synchrony Motion Tracking and Correction technology for its Radixact system in April 2019. Similarly, Elekta received EU Medical Device Regulation (MDR) certification for its newly launched Elekta Harmony linear accelerator in September 2020. Additionally, the companies are focusing on collaborating with other market players to expand their business footprint and geographical presence. For instance, Accuray Inc collaborated with Brainlab to expand Accuray’s CyberKnife platform treatment abilities for the neuro-radiosurgery market in October 2020. Similarly, ViewRay Inc collaborated with VieCure to implement AI informatics into personalized cancer care offerings in April 2020. In January 2020, Brainlab acquired VisionTree and this acquisition was aimed at enhancing patient-driven outcomes with respect to treatment planning, image data generation, and registries.

Component Insights

The treatment planning software segment dominated the market for treatment planning systems and advanced image processing and held the largest revenue share of 87.5% in 2020. This growth is owing to the increasing global prevalence of cancer and the rising demand for advanced accurate oncology therapy solutions. Treatment planning software is being widely adopted due to the increase in awareness regarding its efficiency in cancer treatment using radiotherapy. This software solution included a wide array of tools for radiation therapy practices and serves radiologists with dose distribution data, tissue energy level penetration, beamline navigation to minimize collateral damage. Additional factors attributable to its large market share are increasing public-private partnerships, advancements in healthcare infrastructure, and awareness regarding the benefits of software solutions over conventional practice.

For instance, in February 2021 Fujitsu collaborated with the University of Toronto to develop and streamline radiotherapy planning solutions. Moreover, under treatment planning software solutions auto-contouring software registered the highest market share of 28.6%. Manual contouring lacks accuracy, efficiency, standardization, thereby limiting adoption and increasing demands for full or partly automatic contouring solutions for radiotherapy. Product launches in the auto-contouring segment are also shaping market development. For instance, in June 2020, Mirada Medical launched DLC Expert, online auto-contouring software, and has more than 50 centers as registered users.

However, revenue share in the advanced image processing software segment is expected to grow at a high rate over the forecast period. Medical imaging software is considered one of healthcare’s fastest-growing segments inclusive of multiple image modalities. These software solutions are easily available as open free or paid customized sources. Although the global demand for radiology services is increasing, the rate of trained radiologists is only increasing at half its pace. Therefore, the shortage of trained personnel is boosting demand for advanced image processing solutions.

Technique Insights

The in-room imaging segment dominated the market for treatment planning systems and advanced image processing and accounted for the largest revenue share of 55.5% in 2020. This is mainly owing to technological advancement in radiotherapy solutions. In-room imaging processes include capturing pictures during the time of treatment and provide real-time image datasets. These processes are being implemented due to the need for dosage volume reduction, normal tissue radiotherapy toxicity reduction, and for providing accurate and precise treatment. In-room imaging allows radiologists to overcome challenges posed by movable tumors and target lesions. The increasing awareness of the benefit of in-room imaging has contributed to its largely held market share.

Improved target localization, reduced dosage toxicity, shorter treatment course, and improved tumor control are some of the benefits of using in-room imaging processes. Market players are constantly launching products for the in-room imaging processes market. For instance, in February 2019 Canon Medical Systems launched Aquilion Prime, Acquilion Lightning 80, and Acquilion LB with a radiotherapy package to improve the in-room imaging process.

However, 3D image reconstruction is anticipated to witness a CAGR of 8.2% over the forecast period. These processes use 3D image projections from image datasets using reconstruction techniques such as visualization, triangulation method, photometric stereo handling, and multiple Kinect capturing systems. The benefits of using 3D image reconstruction in treatment planning processes are optimal treatment process realization, applicator selection, dosage distribution planning, and minimizing collateral tissue damage. The rising demand for accurate oncology treatment practices and tackle increasing global cancer prevalence is driving the growth of the 3D image reconstruction segment.

Application Insights

In 2020, the validation of the image registration segment dominated the market for treatment planning systems and advanced image processing and accounted for the largest revenue share of 27.6%. This growth is owing to the importance image registration and creation of image datasets play in a treatment planning process. Image registration forms real-time image datasets from multiple image modalities and anatomical atlases to guide target volume and tissue delineation. These solutions conduct validations on dose distribution, contours, and dosage accumulation through the developed imaged datasets over the therapy course. These solutions are suitable to guide in dose mapping and accumulation. RaySearch Laboratories and Varian Medical Systems are two key players developing solutions for image registration validation.

Global treatment planning system & advanced image processing market share, by application, 2020 (%)

However, adaptive radiotherapy is anticipated to record the fastest growth over the forecast period. Adaptive radiotherapy is used to provide altered radiation therapy to compensate for anatomical and functional changes during the radiotherapy course. Adaptive radiotherapy encompasses functions of in-room imaging, image registration algorithms, image segmentation, and dosage summation. It is being widely used for treating head, neck, and stomach cancers. The rising number of cancer treatment facilities is positively impacting the market growth for adaptive radiotherapy. For instance, in September 2019 Varian introduced Ethos Solution for adaptive radiotherapy powered by artificial intelligence.

Regional Insights

In 2020, North America dominated the market and accounted for the largest revenue share of 38.8% owing to rapid advancements in healthcare infrastructure coupled with increased healthcare expenditure. Rising global cancer prevalence is also a market driving factor in treatment planning systems. The rising demand for effective, accurate, and advanced cancer treatment and care practices in North America has boosted the market growth in this region.

The presence of sophisticated healthcare facilities and cancer research institutes and increased disposable income with an existing reimbursement framework is supporting market development and growth. In North America, cancer accounts for the second leading cause of death. As per Globocan estimates of 2020, U.S. recorded a total of 2.2 million new cancer cases and 0.6 million cancer deaths. Cancer mortality in this region has been declining since 1991 which is due to innovations in treatment practices and early cancer detection.

However, in the Asia Pacific, the market is anticipated to witness a CAGR of 8.8% over the forecast period due to the growth of many developing economies such as India and China. Constant healthcare advancements and widespread adoption of healthcare IT solutions in emerging countries are some of the key factors responsible for market growth. Increasing cancer prevalence and rise in healthcare expenditure by both public and private players are supporting market growth. As per Globocan 2020, Asia Pacific recorded 9,503,710 new cancer cases. Organizations are undertaking initiatives to spread awareness and accelerate penetration. For instance, Asia Pacific Signal and Information Processing Association organizes annual seminars and workshops on topics like image processing and healthcare information technology.

Key Companies & Market Share Insights

Key Companies are following business strategies including diverse product offerings, partnerships and agreements, and ongoing new launches to gain significant market share. Some of these market players have recently launched new software systems in order to extend their solutions portfolio. For instance, in September 2020 Elekta launched a new linear accelerator Elekta Harmony to strengthen their market penetration strategies. Some of the prominent players in the treatment planning systems and advanced image processing market include:

  • Accuray Incorporated

  • Elekta

  • Koninklijke PHILIPS N.V.

  • RaySearch Laboratories

  • Varian Medical Systems

  • Brainlab

  • Prowess Inc.

  • DOSIsoft SA

  • ViewRay Inc.

  • MIM Software Inc.

Treatment Planning Systems And Advanced Image Processing Market Report Scope 

Report Attribute

Details

Market size value in 2021

USD 1.7 billion

Revenue forecast in 2028

USD 3.0 billion

Growth rate

CAGR of 7.8% from 2021 to 2028

Base year for estimation

2020

Actual estimates/Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD Million and CAGR from 2020 to 2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

Component, technique, application, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE

Key companies profiled

Accuray Incorporated; Elekta; Koninklijke Philips NV; RaySearch Laboratories; Varian Medical Systems; Brainlab; Prowess, Inc.; DOSIsoft SA; Viewray, Inc.; MIM Software, Inc.

Customization scope

Free report customization (equivalent to up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global treatment planning system and advanced image processing market report on the basis of component, technique, application, and region:

  • Component Outlook (Revenue, USD Million, 2016 - 2028)

    • Advanced Image Processing Software

    • Treatment Planning Software

      • Auto-Contouring Software

      • Multi-Modality Software

      • PET/CT Deformable Software

      • DICOM-RT Software

  • Technique Outlook (Revenue, USD Million, 2016 - 2028)

    • 3D Image Reconstruction

    • In-Room Imaging

    • Image Registration using Graphics Processor Unit

  • Application Outlook (Revenue, USD Million, 2016 - 2028)

    • Adaptive Radiotherapy

    • Online Monitoring

    • Tracking

    • Dose Accumulation

    • Validation of Image Registration

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • Spain

      • France

      • Italy

      • Russia

    • Asia Pacific

      • China

      • Japan

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East and Africa

      • Saudi Arabia

      • UAE

      • South Africa

Frequently Asked Questions About This Report

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPA norms. All interactions are confidential.

  • GDPR.EU
  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities